Weeding Out Arsenate

A miniscule change in a hydrogen bond angle explains how bacteria can select phosphate over arsenate even in high-arsenate conditions.

Written bySabrina Richards
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

WIKIMEDIA COMMONS, Michael Gäbler A few degrees difference in a single hydrogen bond angle prevents bacteria from importing arsenate in place of phosphate, a molecule integral to energy production, DNA, and enzymatic cascades, according to a new study published today (October 3) in Nature. Arsenate is structurally very similar to phosphate, but the new research shows that certain proteins responsible for importing phosphate are unable to handle arsenate’s slightly larger size, which warps a key hydrogen bond, allowing certain bacterial species grow in high-arsenate environments.

The findings “show how a gatekeeper [protein] keeps arsenate out [of bacteria], so levels don’t accumulate and the bacteria don’t have to worry about toxic effects,” said Ronald Viola, a chemist at the University of Toledo who was not involved in the research.

The study drives a nail in the coffin of a 2010 Science paper in which NASA researchers claimed to have discovered a strain of Halomonas bacteria in Mono Lake, California, that incorporated arsenate, instead of phosphate, into its DNA backbone. The study generated a stir in the scientific community, drawing much press and criticism. The findings were subsequently refuted by several studies, though the paper has not been retracted.

The new work provides a mechanistic explanation for how the bacteria in Mono ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies